MedTrace Logo

The Synbiotics Effects in Polycystic Ovary Syndrome: A Randomized Controlled Trial

NCT06169566 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-12-13

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effect of synbiotics and placebo in Thai women with polycystic ovary syndrome. The main questions it aims to answer are:

* Do synbiotics have a positive effect on the gut microbiome?
* Do synbiotics have a positive effect on reproductive outcomes?
* Do synbiotics have a positive effect on cardiovascular outcomes? Participants will be randomized, and blinded to receive either synbiotics or placebo.

While placebo is a comparison group: Researchers will compare with placebo to see if the effects on reproductive and cardiovascular risk differ.

Conditions

  • PCOS- Polycystic Ovary Syndrome

Interventions

DIETARY_SUPPLEMENT

synbiotics

synbiotics

COMBINATION_PRODUCT

placebo

placebo

Sponsors & Collaborators

  • Maharaj Nakorn Chiang Mai Hospital

    lead OTHER

Principal Investigators

  • Ploywarong Rueangket, MD · Department of obstetrics and gynecoloy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06169566 on ClinicalTrials.gov